Publication:


abstract

OBJECTIVE:

To evaluate the Outcome of genetic amniocentesis in singleton gestation at Songklanagarind Hospital.

MATERIAL AND METHOD:

This was a descriptive study that included all singleton pregnant women who had a second trimester amniocentesis for chromosome studies at the Maternal Fetal Medicine Unit, Department of Obstetrics and Gynecology, Songklanagarind Hospital between January 1998 and 2006 to assess the outcome including risk of fetal loss in such cases.

RESULTS:

Advanced maternal age was the most common indication for amniocentesis. Amniocentesis after positive screening aneuploidy test increased. The fetal loss within 14 days after the procedure was 0.12% (10/8,073). Leakage of amniotic fluid occurred 0.1% (5/8,073) but only one case aborted. Fever occurred in two cases and a case of chorioamnionitis was diagnosed.

CONCLUSION:

The rate of fetal loss within 14 days after amniocentesis in singleton pregnant women was lower than the authors' previous 10 years. The anxiety of the family and difficulty of counseling to the family will be reduced because of a lower complication rate. Moreover the pregnant women who have a high degree of anxiety for genetic abnormalities are a likely choice for genetic amniocentesis if the risk rate regarding the patient's age, ultrasonographic finding, or maternal serum screening is around 0.1%.

Related Articles
Outcome of second trimester amniocentesis in twin pregnancies at Songklanagarind Hospital.
J Med Assoc Thai. 2008
Outcome of second trimester amniocentesis in twin pregnancies at Songklanagarind Hospital.
Hanprasertpong T, Kor-anantakul O, Prasartwanakit V, Leetanaporn R, Suntharasaj T, Suwanrath C. J Med Assoc Thai. 2008 Nov; 91(11):1639-43.
Prenatal screening for fetal aneuploidy in singleton pregnancies.
J Obstet Gynaecol Can. 2011
Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D, Langlois S, Wilson RD, Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada, Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. J Obstet Gynaecol Can. 2011 Jul; 33(7):736-50.
[Genetic amniocentesis in the II Department of Obstetrics and Gynecology of the Medical University of Warsaw].
Ginekol Pol. 2004
[Genetic amniocentesis in the II Department of Obstetrics and Gynecology of the Medical University of Warsaw].
Milewczyk P, Lipiński T, Hamela-Olkowska A, Jalinik K, Czajkowski K, Zaremba J. Ginekol Pol. 2004 Aug; 75(8):603-8.
Review Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Am J Obstet Gynecol. 1998
Review Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Yankowitz J, Fulton A, Williamson R, Grant SS, Budelier WT. Am J Obstet Gynecol. 1998 Mar; 178(3):446-50.
Review Obstetrical complications associated with abnormal maternal serum markers analytes.
J Obstet Gynaecol Can. 2008
Review Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, et al. J Obstet Gynaecol Can. 2008 Oct; 30(10):918-49.